Evaluation of larger side-group functionalities and the side/end-group interplay in ritonavir-like inhibitors of CYP3A4
Samuels, E.R., Sevrioukova, I.F.(2025) Chem Biol Drug Des 
Experimental Data Snapshot
Starting Model: experimental
View more details
(2025) Chem Biol Drug Des 
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Cytochrome P450 3A4 | 487 | Homo sapiens | Mutation(s): 0  Gene Names: CYP3A4, CYP3A3 EC: 1.14.14.1 (PDB Primary Data), 1.14.14.56 (PDB Primary Data), 1.14.14.73 (PDB Primary Data), 1.14.14.55 (PDB Primary Data) | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P08684 (Homo sapiens) Explore P08684  Go to UniProtKB:  P08684 | |||||
PHAROS:  P08684 GTEx:  ENSG00000160868  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P08684 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 2 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
HEM Query on HEM | B [auth A] | PROTOPORPHYRIN IX CONTAINING FE C34 H32 Fe N4 O4 KABFMIBPWCXCRK-RGGAHWMASA-L | |||
A1A4S (Subject of Investigation/LOI) Query on A1A4S | C [auth A] | N-[(2S)-1-(1H-indol-3-yl)-3-{[(2R)-1-oxo-3-phenyl-1-{[3-(pyridin-3-yl)propyl]amino}propan-2-yl]sulfanyl}propan-2-yl]pyridine-3-carboxamide C34 H35 N5 O2 S ABZLMAOSAJFABX-BHDXBOSCSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 75.399 | α = 90 |
b = 99.77 | β = 90 |
c = 122.64 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
MOSFLM | data reduction |
SCALA | data scaling |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Institute of Environmental Health Sciences (NIH/NIEHS) | United States | ES025767 |